Medical Science Liaison at Legend Biotech

Atlanta, Georgia, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, OncologyIndustries

Requirements

Live within assigned field-based territory (Southeast: LA, AL, MS, GA) or within a 30-minute commute from the nearest territory border, focusing on both community and academic sites
Excellent oral presentation and communication skills for clinical presentations and information delivery to academic and community healthcare providers in group and one-on-one settings

Responsibilities

Identify KOLs within the assigned territory and establish and maintain scientific relationships with KOLs in both academic and community institutions
Execute activities at the assigned territory level in full alignment with Medical Affairs strategies and tactics
Assist in the oversight of Legend Biotech sponsored clinical trial sites, including site identification, patient accrual discussions, site initiation or feasibility, and serve as the primary field-based point of contact between investigators and members of the Legend Biotech Medical Affairs and Clinical Development teams; addressing AE management and education as needed
Collaborate with cross-functional partners, including those part of strategic alliances
Assist with implementation and engagement of key opinion leader participation in advisory boards, consultant meetings, and other scientific meetings
Collect and communicate clinical insights and intelligence on the market environment, clinical strategies, competition, and other developments relevant to Legend Biotech's success
Represent and support Legend Biotech at Hematology/Oncology scientific meetings including congresses, symposia, advisory boards, and investigator meetings; interpret and report findings with recommendations for action to relevant internal stakeholders
Serve as the primary local point of contact for investigators and their research staff who may participate in company sponsored and investigator initiated clinical trials
Provide clinical presentations and information delivery to academic and community healthcare providers in both group and one-on-one settings
Relay important medical insights to key Legend Biotech stakeholders as gathered from field interactions
Engage identified key opinion leaders (KOLs) and other healthcare professionals (HCPs) through high-level scientific support for research activities, publications, education, consulting, and other Medical Affairs initiatives
Provide credible, compliant, fair-balanced, and ethical scientific exchange with members of the healthcare community, consistent with the direction and focus defined by the Legend Biotech Medical Affairs team
Provide direct education for healthcare professionals treating oncology patients on clinical data, adverse event management, and mechanism of action for commercial and pipeline assets

Skills

KOL Engagement

Scientific Exchange

Medical Affairs

Oncology

Multiple Myeloma

CAR-T Therapy

Immunotherapy

Adverse Event Management

Clinical Data Education

Mechanism of Action

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free